Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2026-03-06 @ 9:39 PM
Study NCT ID:
NCT01806961
Status:
TERMINATED
Last Update Posted:
2016-08-03
First Post:
2013-03-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.
Sponsor:
Spirig Pharma Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SP848-AKEx-1209
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None